Evidence map›Paper›PMID 28704378›Full record

ArticlePloS one2017

Characterizing properties of non-estrogenic substituted bisphenol analogs using high throughput microscopy and image analysis.

Adam T Szafran, Fabio Stossi, Maureen G Mancini, Cheryl L Walker, Michael A Mancini

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Binary Classification of the Endocrine Disrupting Chemicals by Artificial Neural Networks.ESCAPE. European Symposium on Computer Aided Process Engineering · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Adam T SzafranMolecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
Fabio StossiMolecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
Maureen G ManciniMolecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
Cheryl L WalkerMolecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
Michael A ManciniMolecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
Baylor College of Medicine · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Single cell, multi-parametric high throughput platform to classify endocrine disruptor potential of mixturesP42ES027704 · NIEHS · TEXAS A&M UNIVERSITY · PI Thomas Joseph McDonald · 2017 to 2026
$21.2M
TRANSGENIC MOUSE MODELS TO STUDY OVARIAN FUNCTIONU54HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI O'MALLEY, BERT W · 1998 to 2013
$19.9M
Multidisciplinary K12 Urologic Research (KURe) Career Development ProgramK12DK083014 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI LAMB, DOLORES JEAN · 2008 to 2017
$6.0M
TARGETED GENOMICS FACILITY COREP30ES023512 · NIEHS · TEXAS A&M AGRILIFE RESEARCH · PI DEUTZ, NICOLAAS E · 2014 to 2017
$3.3M
Epigenetic Programmers Targeted During Developmental ReprogrammingR01ES023206 · NIEHS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI BEDFORD, MARK T., MANCINI, MICHAEL A. · 2013 to 2016
$2.3M
GROWTH AND DIFFERENTIATION IN EUKARYOTEST32HD007495 · NICHD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI KINTNER, CHRISTOPHER ROBERT · 1995 to 2009
$1.6M
TRANSGENIC ANIMAL--COREP30HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI GLASSER, STANLEY R · 1985 to 1997
–
NCI NIH HHS P30 CA125123NICHD NIH HHS P30 HD007495NICHD NIH HHS T32 HD007495NICHD NIH HHS U54 HD007495NIDDK NIH HHS K12 DK083014NIDDK NIH HHS P30 DK056338NIEHS NIH HHS P30 ES023512NIEHS NIH HHS P42 ES027704NIEHS NIH HHS R01 ES023206
6 · The paper itself

Abstract

Animal studies have linked the estrogenic properties of bisphenol A (BPA) to adverse effects on the endocrine system. Because of concerns for similar effects in humans, there is a desire to replace BPA in consumer products, and a search for BPA replacements that lack endocrine-disrupting bioactivity is ongoing. We used multiple cell-based models, including an established multi-parametric, high throughput microscopy-based platform that incorporates engineered HeLa cell lines with visible ERα- or ERβ-regulated transcription loci, to discriminate the estrogen-like and androgen-like properties of previously uncharacterized substituted bisphenol derivatives and hydroquinone. As expected, BPA induced 70-80% of the estrogen-like activity via ERα and ERβ compared to E2 in the HeLa prolactin array cell line. 2,2' BPA, Bisguaiacol F, CHDM 4-hydroxybuyl acrylate, hydroquinone, and TM modified variants of BPF showed very limited estrogen-like or androgen-like activity (< 10% of that observed with the control compounds). Interestingly, TM-BFP and CHDM 4-hydroxybuyl acrylate, but not their derivatives, demonstrated evidence of anti-estrogenic and anti-androgenic activity. Our findings indicate that Bisguaiacol F, TM-BFP-ER and TM-BPF-DGE demonstrate low potential for affecting estrogenic or androgenic endocrine activity. This suggest that the tested compounds could be suitable commercially viable alternatives to BPA.

Indexed as

Benzhydryl CompoundsBisphenol A CompoundsEstrogen Receptor alphaEstrogen Receptor betaEstrogens, Non-SteroidalHeLa CellsHigh-Throughput Screening AssaysHumansHydroquinonesMCF-7 CellsMicroscopyMolecular StructurePhenolsTranscription, GeneticBenzhydryl Compoundsbisphenol ABisphenol A CompoundsESR1 protein, humanESR2 protein, humanEstrogen Receptor alphaEstrogen Receptor betaEstrogens, Non-SteroidalhydroquinoneHydroquinonesPhenols

Identifiers

PMID28704378
PMCPMC5509144
OpenAlexW2734980640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.